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Background: Benign and malignant bone tumors can present similar imaging features. This study aims to evaluate
the significance of apparent diffusion coefficients (ADC) in differentiating between benign and malignant bone
tumors.
Methods: A total of 187 patients with 198 bone masses underwent diffusion-weighted (DW) magnetic resonance
(MR) imaging. The ADC values in the solid components of the bone masses were assessed. Statistical differences
between the mean ADC values in the different tumor types were determined by Student’s t-test.
Results: Histological analysis showed that 84/198 (42.4%) of the bone masses were benign and 114/198 (57.6%)
were malignant. There was a significant difference between the mean ADC values in the benign and malignant
bone lesions (P <0.05). However, no significant difference was found in the mean ADC value between non-ossifying
fibromas, osteofibrous dysplasia, and malignant bone tumors. When an ADC cutoff value ≥1.10 × 10−3 mm2/s
was applied, malignant bone lesions were excluded with a sensitivity of 89.7%, a specificity of 84.5%, a positive
predictive value of 82.6%, and a negative predictive value of 95.3%.
Conclusions: The combination of DW imaging with ADC quantification and T2-weighted signal characteristics of
the solid components in lesions can facilitate differentiation between benign and malignant bone tumors.
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Preoperative characterization of benign, malignant, and
tumor-like bone lesions is important in order to make
informed choices regarding treatment strategies. Al-
though plain film radiography is still considered the
first-line imaging modality for assessing the nature and
defining the characteristics of primary bone lesions, cer-
tain areas of the musculoskeletal system may be difficult
to profile in plain films due to overlapping structures
[1]. Computerized tomography can provide more de-
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unless otherwise stated.reaction, subtle matrix mineralization, and endosteal
scalloping [2]. Magnetic resonance (MR) imaging is con-
sidered the most advanced imaging technique and the
most sensitive for evaluating changes in bone-marrow
and defining the extent of a lesion, particularly when
plain films or computerized tomography findings are
suboptimal or indeterminate; however, it is not always
the most specific. Despite their respective advantages,
none of these imaging techniques can reliably differen-
tiate between benign and malignant bone tumors, as
many lesions are non-specific and display varying im-
aging characteristics on T1- and T2-weighted images.
MR characterization of bone lesions can be improved by
the use of MR diffusion-weighted (DW) imaging, as this
is sensitive to changes in the microdiffusion of water
into both intracellular and extracellular spaces. Thetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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the cellularity of neoplasms. Apparent diffusion co-
efficients (ADC) are largely proportional to the ratio of
extracellular and intracellular components, cell density,
intracellular organelles, matrix fibers, and soluble mac-
romolecules. Tumors with different levels of cellularity
have different ADC values corresponding to changes in
restricted diffusion [3-6].
The purposes of this study were to clarify the relation-
ship between ADC values in the solid components of
bone masses and to evaluate its supplementary use in dif-
ferentiating between benign and malignant bone tumors.
Methods
Patient selection
This study received approval from our institutional
(Xinhua Hospital) review board and the requirement to
obtain written informed consent was waived. A total of
178 patients who had been diagnosed with bone tumors
between January 2005 and March 2014 were enrolled in
this study. The selection criteria were as follows: the
diagnosis was confirmed by histological biopsy or surgery,
MR imaging was performed using a 3.0 T magnet, and
both conventional MR imaging with DW imaging and
contrasted-enhancement MR imaging were performed. A
retrospective evaluation of the MR imaging data was
undertaken.
MR imaging protocol
All patients underwent MR imaging with a 3.0T MR unit
(GE Medical Systems; Milwaukee, WI, USA). Axial non-
contrast T1-weighted (TR/TE, 400 to 500/10 to 12 ms) and
axial T2-weighted (TR/TE, 4,000 to 5,000/100 to 120 ms)
imaging were performed with chemical shift-selective fat
saturation pulse using the following parameters: slice thick-
ness, 5 mm; gap, 1 mm; field of view, 20 to 40 cm; matrix,
256 × 256; and excitation, 2. Sagittal T1-weighted and T2-
weighted (TR/TE, 3,000 to 5,000/100 to 110 ms) fast spin-
echo imaging without chemical shift-selective fat saturation
pulse were also performed using the parameters described
above. DW-MR imaging was performed in the axial or sa-
gittal plane prior to administration of contrast medium
using a single-shot echo-planar imaging sequence (TR/TE
effective range, 6,000 to 8,000/70 to 100 ms; slice thickness/
intersection gap, 5/1 mm; field of view, 20 to 40 cm; matrix,
128 × 128; excitation, 2. A b-value of 0 and 1,000 s/mm2
were also applied in three orthogonal directions. Post-
contrast-enhanced axial and sagittal T1-weighted imaging
were also performed using the parameters described above
with the exception of the 5 mm slice thickness.
MR and MR-DW image analysis
Conventional MR and DW-MR imaging data were ana-
lyzed on an Advantage Windows workstation 4.2 (GEHealthcare, Milwaukee, WI, USA). Image analysis was
carried out by two radiologists in consensus (with 7 and
9 years’ experience in musculoskeletal MR imaging, re-
spectively). The signal intensity of the solid components
on T2-weighted MR images was defined as intermediate
or high, relative to the muscle signal and signal intensity
of the solid portions exhibiting enhancement post-
injection. The signal intensity of the solid components at
b = 1,000 s/mm2 on the DW images was defined as
intermediate or low relative to that of the muscle.
Data calculation and analysis
The solid components of the lesions were identified on
T2-weighted and post-contrast T1-weighted images, and
were matched on ADC maps. The ADC values of the
solid components in each tumor were measured on DW
images by a radiologist using an Advantage Windows
workstation 4.2 and FuncTool software (GE Medical
Systems). In order to minimize variability, the largest
possible region of interest (ROI) was placed manually in
the solid part of the tumor in each image (range: 10 to
80 mm2). If the lesion exhibited irregular or heteroge-
neous solid components, two or three ROIs were drawn
within the targeted components and the mean ADC
value was calculated for the analyses.
Statistical analysis
All analyses were performed using SPSS v. 13.0 software
for Windows (SPSS; Chicago, IL, USA). Differences in the
mean ADC values of the bone tumors between the benign
and malignant groups were evaluated using Student’s
t-test. A value <0.05 was considered statistically sig-
nificant. Biopsy or surgical pathology results were used as
reference standards for assessment of the bone tumors.
Receiver operating characteristic curve analysis was per-
formed to assess the diagnostic performance of the mean
ADC values in characterization of benign and malignant
bone tumors.
Results
Demographics and histopathological characteristics
The histopathological types of 198 bone masses in the
178 patients are summarized in Table 1. The study
group consisted of 81 males and 97 females, with a
mean age of 31.52 ± 28.31 years (range: 1 to 92 years).
These included 131 patients with solitary bone tumors,
22 patients with 28 Langerhans cell histiocytosis, and 25
patients (n = 15 lung cancer, n = 4 breast cancer, n = 3
prostate cancer, and n = 3 colorectal cancer) with 39
metastatic bone tumors. A total of 84/198 (42.4%) bone
masses were benign and 114/198 (57.6%) were malig-
nant. The diameters of the lesions in the benign group
were 1.5 to 11.2 cm (median: 3.7 cm) and 1.2 to 16 cm
(median, 4.1 cm) in the malignant group.
Table 1 Histological type and apparent diffusion coefficient (ADC) values of 198 bone masses (mean ± SD× 10−3 mm2/s)
Type of bone masses No. of lesions High SI on T2WI (%) High SI on DWI (%) Range of ADC values Mean ADC value
Benign bone lesions 84 54 (64.3) 50 (59.5) 0.49–1.59 1.17 ± 0.36
Non-ossifying fibroma 17 4 (23.5) 2 (11.8) 0.49–0.99 0.78 ± 0.17
Osteofibrous dysplasia 18 3 (16.7) 1 (5.6) 0.89–1.19 0.97 ± 0.17
Chondromyxoid fibroma 6 5 (83.3) 4 (66.7) 1.18–1.59 1.33 ± 0.15
Langerhans cell histiocytosis 28 28 (100) 28 (100) 0.96–1.55 1.29 ± 0.18
Giant cell tumor of bone 15 14 (93.3) 15 (100) 0.98–1.47 1.21 ± 0.20
Malignant bone lesions 114 101 (88.6) 105 (92.1) 0.58–1.35 0.86 ± 0.20
Chordoma 27 21 (77.8) 24 (88.9) 0.59–1.11 0.80 ± 0.14
Ewing sarcoma 9 6 (66.7) 7 (77.8) 0.70–0.91 0.82 ± 0.07
Osteosarcoma 8 6 (75.0) 5 (62.5) 0.87–1.02 0.97 ± 0.08
Chondrosarcoma 12 10 (83.0) 11 (91.7) 0.69–1.21 0.94 ± 0.15
Plasmacytoma 8 8 (100) 8 (100) 0.68–1.12 0.86 ± 0.15
Primary lymphoma 11 11 (100) 11 (100) 0.68–1.09 0.87 ± 0.14
Metastatic bone tumor 39 39 (100) 39 (100) 0.58–1.12 0.81 ± 0.14
SI, Signal intensity; T2WI, T2-weighted image; DWI, Diffusion-weighted image.
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The percentage of T2-weighted MR images of the solid
components in bone masses giving intermediate or high
signal intensities was significantly lower in the benign
tumor group compared to the malignant tumor group
(64.3% and 88.6%, respectively; P <0.01). The 84 benign
lesions with homogeneous or heterogeneous low signal
intensities included 76.5% non-ossifying fibromas, 83.3%
osteofibrous dysplasia tumors, 16.7% chondromyxoid
fibromas, and 6.7% giant cell tumors of bone.
Evaluation of the bone masses by DW imaging at
b = 1,000 s/mm2, revealed that a significantly higher pro-
portion of malignant lesions exhibited a high signal in-
tensity within the solid components of the bone masses
compared to those in benign lesions (92.1% and 59.5%, re-
spectively; P <0.05). Further analysis of the images showed
that the presence of a solid component with high signal
intensity on T2-weighted images and high signal intensity
on DW images with low ADC values (<1.10 × 10−3 mm2/s,
at b = 1,000 s/mm2) could be considered predictive of ma-
lignancy (Figure 1). Conversely, the presence of a solid
component with high or low signal intensity on T2-
weighted images and low signal intensity on DW images
with high ADC values (≥1.10 × 10−3 mm2/s, at b = 1,000 s/
mm2), or low signal intensity on T2-weighted images and
low signal intensity DW images with low ADC values
(<1.10 × 10−3 mm2/s, at b = 1,000 s/mm2) could be con-
sidered predictive of a benign mass (Figure 2).
ADC analysis
The mean ADC values of the solid components in the
bone masses were determined for each group. There was
considerable overlap in the range of values observed withinthe benign and malignant bone tumors; however, the mean
ADC value for benign tumors (1.17 ± 0.36 × 10−3 mm2/s)
was significantly higher than that in malignant tumors
(0.87 ± 0.20 × 10−3 mm2/s; P <0.05). When the tumor sub-
types were compared, no significant difference in the
ADC values was found between the non-ossifying fibro-
mas or osteofibrous dysplasia and malignant bone tumors
(P >0.05). When an ADC cutoff value ≥1.10 × 10−3 mm2/s
was applied, the benign and malignant bone tumors could
be differentiated with a sensitivity of 89.7%, a specificity of
84.5%, a positive predictive value of 82.6%, and a negative
predictive value of 95.3%, suggesting that this may be the
optimal cutoff value for the ADC.
Discussion
Our results demonstrated that the presence of a solid
component in bone lesions with high signal intensity on
DW and T2-weighted images, combined with low ADC
values can be used to distinguish between malignant and
benign bone lesions. These findings suggested that DW
imaging with quantitative analysis of ADCs may improve
the diagnostic performance of bone MR imaging, and
provide clinically valuable information on the tumor
microenvironment.
DW imaging has been extensively investigated for its
ability to characterize tissue in various lesions. It has been
shown to increase the accuracy in distinguishing benign
from malignant masses, and discriminating between meta-
static and benign lymphadenopathies. It has also proved
successful in the evaluation of cerebral ischemia and intra-
cranial tumors [1,3,4]. Malignant tumors with a high nu-
clear/cytoplasmic ratio, hypercellularity, and a reduced
extracellular matrix often have restricted mobility of water
Figure 1 A 7-year-old girl with an eosinophilic granuloma. (A) Axial T1-weighted image showing an isointense small round mass within the
occipital bone (arrow). (B) An axial T2-weighted image reveals that the mass is hyperintense (arrow). (C) Axial DW imaging reveals that the mass
is slightly hyperintense with a high ADC value (circled area: ADC = 1.50 × 10−3 mm2/s) (arrow). (D) Axial enhanced T1-weighted image showing
the lesion with marked enhancement (arrow).
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generally have higher ADC values. These variations were
reflected in our results. Although there was some overlap
in the ADC values between the malignant and benign
bone lesions, the mean ADC values in the 114 malignant
bone tumors was significantly lower than that in the 84
benign bone masses. Our results further revealed that the
optimal ADC cutoff value for differentiating between be-
nign and malignant tumors was 1.10 × 10−3 mm2/s. This
result was consistent with those given in previous reports
[7-12].
A study by Hayashida et al. [4] evaluated the contribu-
tion of DW imaging in combination with quantitative ana-
lysis of ADCs in the characterization of 20 bone masses,
including 8 solitary bone cysts, 5 fibrous dysplasia tumors,
and 7 chondrosarcomas. Their results suggested that this
method of imaging bone lesions was not suitable for
differentiating between benign and malignant bone le-
sions. This apparent discrepancy may have been due todifferences in pathological bone architecture. However,
our results revealed a significant difference in the mean
ADC values of the solid components between malignant
and benign bone lesions. In addition, our results showed
low ADC values in 17 non-ossifying fibromas and 18
osteofibrous dysplasia tumors. These may have been due
to the presence of abundant collagen-producing fibroblas-
tic cells and a dense network of collagen fibers within the
extracellular matrix, which can restrict the Brownian mo-
tion of water molecules. This characteristic may also have
been responsible for the absence of a significant difference
between the mean ADC values of non-ossifying fibromas
or osteofibrous dysplasia tumors and malignant bone
lesions.
Our results showed that 88.6% of the T2-weighted im-
ages of solid components in malignant tumors displayed
high signal intensities, compared to 11.4% which dis-
played low signal intensities. However, this value in-
creased to 92.1% when the DW images with low ADC
Figure 2 A 23-year-old man with an osteosarcoma. (A) An axial T1-weighted image showing a hypointense left tibial osteosarcoma mass
(arrow). (B) Axial T2-weighted image showing that the mass has high signal intensity (arrow). (C) Axial DW imaging reveals that the mass is
hyperintense with a low ADC value (circled area: ADC = 0.985 × 10−3 mm2/s). (D) Axial contrast-enhanced T1-weighted image shows marked
enhancement of the bone mass.
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signal intensity on T2-weighted images and high signal
intensity on DW images may have resulted from solid
components with increased nuclear/cytoplasmic ratios
and hypercellularity due to a reduction in both the
extracellular matrix and the diffusion space of water pro-
tons in the extracellular and intracellular dimensions. In
addition, the low signal intensity on T2-weighted images
and DW images of benign bone lesions, such as non-
ossifying fibromas and osteofibrous dysplasia tumors,
may have been due to the high density of fibers, low cel-
lularity, and low water content in both the extracellular
and intracellular spaces [4,13]. Our findings confirmed
that a high signal intensity on DW images of solid com-
ponents with low ADC values can serve as a useful cri-
terion for predicting malignancy in bone lesions, and
that a low signal intensity on T2-weighted images and
DW images of solid components with low ADC values
may be an effective criterion for predicting the presence
of benign disease.
Our study had the following limitations: DW imaging
often has poor spatial resolution, therefore, drawing the
ROI on DW images while viewing T2-weighted or con-
trasted T1-weighted images may result in information
bias. A better approach may be to fuse the DW images
of solid components that show an abnormal signal at
b = 1,000 × 10−3 mm2/s onto structural images in order
to accurately position the ROI. Furthermore, the proposed
value for the ADC threshold will need to be validated in a
larger group of patients, as the ADC can be affected by
many factors, including magnetic susceptibility, spatialresolution, signal to noise ratio, and the pathophysio-
logical characteristics of the bone lesions.
Conclusions
DW imaging is a potentially valuable method for differen-
tiating between benign and malignant bone tumors as it
offers both high sensitivity and specificity. Bone masses
with solid components that exhibit low signal intensity on
T2-weighted and DW images and low ADC values are in-
variably benign.
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